Efficacy and safety of mefloquine, artesunate, mefloquine–artesunate, tribendimidine, and praziquantel in patients with Opisthorchis viverrini: a randomised, exploratory, open-label, phase 2 trial - Concepedia

Concepedia

Publication | Closed Access

Efficacy and safety of mefloquine, artesunate, mefloquine–artesunate, tribendimidine, and praziquantel in patients with Opisthorchis viverrini: a randomised, exploratory, open-label, phase 2 trial

84

Citations

24

References

2010

Year

Phonepasong Ayé Soukhathammavong, Peter Odermatt, Somphou Sayasone, Youthanavanh Vonghachack, Penelope Vounatsou, Christoph Hatz, Kongsap Akkhavong, Jennifer Keiser

The Lancet Infectious Diseases

Antiparasitic AgentMedicineOpisthorchis ViverriniPharmacotherapyPharmacology

References

	Year	Citations

Page 1